抗コクシジウム薬市場：タイプ別、動物タイプ別-2025～2030年の世界予測

抗コクシジウム薬市場は、2023年に16億2,000万米ドルと評価され、2024年には17億6,000万米ドルに達すると予測され、CAGR 9.39％で成長し、2030年には30億4,000万米ドルに達すると予測されています。

抗コクシジウム薬市場の範囲には、家畜、特に家禽と牛に影響を与える寄生虫感染症であるコクシジウム症の予防と治療を目的とした医薬品が含まれます。これらの医薬品は、家畜の健康を維持し、生産性を向上させ、農業ビジネス部門の品質を確保するために不可欠です。その用途は主に予防的で、飼料や水に混ぜて投与され、家畜の密度が感染リスクを増大させる環境では極めて重要です。最終用途には主に養鶏場、牧畜場、動物病院が含まれます。食肉や乳製品用タンパク質に対する消費者の需要の高まりが、特に農業生産高の向上に重点を置く発展途上地域における抗コクシジウム薬の必要性を高めています。主要成長要因としては、より効果的で安全な薬剤製剤を可能にするバイオテクノロジーの進歩、動物の健康基準を維持するための規制支援、世界の家畜人口の増加などが挙げられます。環境に優しい医薬品の開発、有機食肉市場への対応、アフリカやアジアの一部など未開拓地域における流通チャネルの拡大などに潜在的なビジネス機会があります。しかし、薬剤耐性のコクシジウム株の出現、EUなどの主要市場における厳しい規制の枠組み、抗生物質不使用の食肉を求める消費者動向の高まりといった要因によって、市場の成長は阻まれています。ワクチンのような代替戦略の調査や、薬剤と改良された畜産プラクティスを組み合わせた総合的害虫管理の採用には技術革新の可能性があります。市場の性質は競争的で細分化されており、地元企業と世界的大企業がそれぞれの製品を差別化するために研究開発に投資しているのが特徴です。企業は、精密畜産とデータ分析における技術的進歩を活用して、治療レジメンを最適化することができます。全体として、市場は世界の農業動向に後押しされて堅調な成長が見込まれる一方、競合を維持し事業成長を促進するために、参入企業は規制状況を乗り切り、サステイナブル研究セグメントに投資する必要があります。

市場力学：急速に進化する抗コクシジウム薬市場の主要市場洞察を公開

抗コクシジウム薬市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネス機会の獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 家畜におけるコクシジウム症の流行増加
  • 家畜飼育方法の改善
  • 動物福祉の向上に向けた政府投資の増加
• 市場抑制要因
  • 抗コクシジウム薬に関する政府の厳しい規制
• 市場機会
  • 先進的な抗コクシジウム薬の開発
  • メーカーによるコクシジウム症管理イニシアチブの採用
• 市場課題
  • 代替医薬品や治療法の入手可能性

ポーターのファイブフォース：抗コクシジウム薬市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォースフレームワークは、企業の競合を評価し、戦略的機会を探るための明確な手法を記載しています。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これら洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：抗コクシジウム薬市場における外部からの影響の把握

外部マクロ環境要因は、抗コクシジウム薬市場の業績力学を形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を記載しています。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析：抗コクシジウム薬市場における競合情勢の把握

抗コクシジウム薬市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、セグメント化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニングマトリックス：抗コクシジウム薬市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、抗コクシジウム薬市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨：抗コクシジウム薬市場における成功への道筋を描く

抗コクシジウム薬市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネス機会を活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目セグメントを網羅した市場の包括的な分析を提供しています。

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力を評価します。

2.市場の開拓度：新興市場における成長機会を特定し、既存セグメントにおける拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを記載しています。

3.市場の多様化：最近の製品発売、未開拓の地域、産業の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発とイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報に基づいた意思決定を行う上で役立つ重要な質問にも回答しています。

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、地域はどこか？

3.市場を形成する主要技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 家畜におけるコクシジウム症の蔓延増加
    • 畜産プラクティスの改善が進む
    • 動物福祉の向上に向けた政府の投資の増加
  • 抑制要因
    • 抗コクシジウム薬に対する厳格な政府規制
  • 機会
    • 先進的抗コクシジウム薬の開発
    • メーカーによるコクシジウム症管理の取り組みの採用
  • 課題
    • 代替医療や治療法の利用可能性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 法律
  • 環境

第6章 抗コクシジウム薬市場：タイプ別

• イントロダクション
• 抗生物質抗コクシジウム
• 化学誘導抗コクシジウム剤
• イオンフォア抗コクシジウム剤

第7章 抗コクシジウム薬市場：動物タイプ別

• イントロダクション
• 養殖
• 家畜
• 家禽

第8章 南北アメリカの抗コクシジウム薬市場

• イントロダクション
• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋の抗コクシジウム薬市場

• イントロダクション
• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの抗コクシジウム薬市場

• イントロダクション
• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析、2023年
• FPNVポジショニングマトリックス、2023年
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Bioproperties Pty Ltd.
• Boehringer Ingelheim International GmbH
• Ceva Sante Animale
• Cronus Pharma
• Elanco Animal Health Inc.
• Fengchen Group Co., Ltd.
• Hipra Laboratories, S.A.
• Huvepharma EOOD
• Impextraco NV
• Intas Pharmaceuticals Ltd.
• Jurox Pty Limited
• Kaken Pharmaceutical Co. Ltd.
• Kemin Industries Inc.
• Merck & Co., Inc.
• Novartis AG
• Phibro Animal Health Corporation
• Qilu Animal Health Products Co., Ltd.
• Salius Pharma Pvt. Ltd.
• TOKU-E
• VH Group
• Virbac Group
• VIVAN Life Sciences Pvt. Limited
• Zoetis Inc.

LIST OF FIGURES

• FIGURE 1. ANTICOCCIDIAL DRUGS MARKET RESEARCH PROCESS
• FIGURE 2. ANTICOCCIDIAL DRUGS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. ANTICOCCIDIAL DRUGS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. ANTICOCCIDIAL DRUGS MARKET DYNAMICS
• TABLE 7. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANTIBIOTIC ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY CHEMICAL DERIVATIVE ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY IONOPHORE ANTICOCCIDIALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY AQUACULTURE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY LIVESTOCK, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL ANTICOCCIDIAL DRUGS MARKET SIZE, BY POULTRY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 17. AMERICAS ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 19. ARGENTINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 21. BRAZIL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 23. CANADA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 25. MEXICO ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 28. UNITED STATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 31. ASIA-PACIFIC ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 33. AUSTRALIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 35. CHINA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 37. INDIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 39. INDONESIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 41. JAPAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 43. MALAYSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 45. PHILIPPINES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 47. SINGAPORE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 49. SOUTH KOREA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 51. TAIWAN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 53. THAILAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 55. VIETNAM ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 58. EUROPE, MIDDLE EAST & AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 60. DENMARK ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 62. EGYPT ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 64. FINLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 66. FRANCE ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 68. GERMANY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 70. ISRAEL ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 72. ITALY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 74. NETHERLANDS ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 76. NIGERIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 78. NORWAY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 80. POLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 82. QATAR ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 84. RUSSIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 86. SAUDI ARABIA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH AFRICA ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 90. SPAIN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 92. SWEDEN ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 94. SWITZERLAND ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 96. TURKEY ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 98. UNITED ARAB EMIRATES ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
• TABLE 100. UNITED KINGDOM ANTICOCCIDIAL DRUGS MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
• TABLE 101. ANTICOCCIDIAL DRUGS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 102. ANTICOCCIDIAL DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

The Anticoccidial Drugs Market was valued at USD 1.62 billion in 2023, expected to reach USD 1.76 billion in 2024, and is projected to grow at a CAGR of 9.39%, to USD 3.04 billion by 2030.

The scope of the anticoccidial drugs market encompasses pharmaceuticals designed to prevent and treat coccidiosis, a parasitic infection affecting livestock, particularly poultry and cattle. These drugs are essential for sustaining animal health, improving productivity, and ensuring quality in the agribusiness sector. Their application is primarily preventive, administered in feed or water, and critical in environments where livestock density increases infection risks. The end-use scope primarily includes poultry farms, cattle farms, and veterinary clinics. A growing consumer demand for meat and dairy protein drives the necessity for anticoccidial drugs, especially in developing regions focusing on enhancing agricultural outputs. Key growth influencers include advancements in biotechnology enabling more effective and safer drug formulations, regulatory support for maintaining animal health standards, and rising global livestock population. Potential opportunities lie in developing eco-friendly drugs, catering to the organic meat market, and expanding distribution channels in underpenetrated regions such as parts of Africa and Asia. However, market growth is challenged by factors such as the emergence of drug-resistant coccidial strains, stringent regulatory frameworks in key markets like the EU, and growing consumer trends towards antibiotic-free meat. There is innovation potential in researching alternative strategies like vaccines, and adopting integrated pest management combining drugs with improved animal husbandry practices. The market's nature is competitive and fragmented, characterized by local players and global giants investing in R&D to differentiate their offerings. Companies can capitalize on technological advancements in precision livestock farming and data analytics to optimize treatment regimens. Overall, while the market offers solid growth prospects driven by global agricultural trends, players must navigate regulatory landscapes and invest in sustainable research areas to maintain competitiveness and foster business growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Anticoccidial Drugs Market

The Anticoccidial Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising prevalence of coccidiosis in livestock
  • Growing improvements in animal husbandry practices
  • Increasing government investments in improving animal welfare
• Market Restraints
  • Stringent government regulations for anticoccidial drugs
• Market Opportunities
  • Development of advanced anticoccidial drugs
  • Introduction of coccidiosis management initiatives by manufacturers
• Market Challenges
  • Availability of alternative medicines and treatments

Porter's Five Forces: A Strategic Tool for Navigating the Anticoccidial Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Anticoccidial Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Anticoccidial Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Anticoccidial Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Anticoccidial Drugs Market

A detailed market share analysis in the Anticoccidial Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Anticoccidial Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Anticoccidial Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Anticoccidial Drugs Market

A strategic analysis of the Anticoccidial Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Anticoccidial Drugs Market, highlighting leading vendors and their innovative profiles. These include Bioproperties Pty Ltd., Boehringer Ingelheim International GmbH, Ceva Sante Animale, Cronus Pharma, Elanco Animal Health Inc., Fengchen Group Co., Ltd., Hipra Laboratories, S.A., Huvepharma EOOD, Impextraco NV, Intas Pharmaceuticals Ltd., Jurox Pty Limited, Kaken Pharmaceutical Co. Ltd., Kemin Industries Inc., Merck & Co., Inc., Novartis AG, Phibro Animal Health Corporation, Qilu Animal Health Products Co., Ltd., Salius Pharma Pvt. Ltd., TOKU-E, VH Group, Virbac Group, VIVAN Life Sciences Pvt. Limited, and Zoetis Inc..

Market Segmentation & Coverage

This research report categorizes the Anticoccidial Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Antibiotic Anticoccidials, Chemical Derivative Anticoccidials, and Ionophore Anticoccidials.
• Based on Animal Type, market is studied across Aquaculture, Livestock, and Poultry.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising prevalence of coccidiosis in livestock
    • 5.1.1.2. Growing improvements in animal husbandry practices
    • 5.1.1.3. Increasing government investments in improving animal welfare
  • 5.1.2. Restraints
    • 5.1.2.1. Stringent government regulations for anticoccidial drugs
  • 5.1.3. Opportunities
    • 5.1.3.1. Development of advanced anticoccidial drugs
    • 5.1.3.2. Introduction of coccidiosis management initiatives by manufacturers
  • 5.1.4. Challenges
    • 5.1.4.1. Availability of alternative medicines and treatments
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Anticoccidial Drugs Market, by Type

• 6.1. Introduction
• 6.2. Antibiotic Anticoccidials
• 6.3. Chemical Derivative Anticoccidials
• 6.4. Ionophore Anticoccidials

7. Anticoccidial Drugs Market, by Animal Type

• 7.1. Introduction
• 7.2. Aquaculture
• 7.3. Livestock
• 7.4. Poultry

8. Americas Anticoccidial Drugs Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Anticoccidial Drugs Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Anticoccidial Drugs Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Bioproperties Pty Ltd.
• 2. Boehringer Ingelheim International GmbH
• 3. Ceva Sante Animale
• 4. Cronus Pharma
• 5. Elanco Animal Health Inc.
• 6. Fengchen Group Co., Ltd.
• 7. Hipra Laboratories, S.A.
• 8. Huvepharma EOOD
• 9. Impextraco NV
• 10. Intas Pharmaceuticals Ltd.
• 11. Jurox Pty Limited
• 12. Kaken Pharmaceutical Co. Ltd.
• 13. Kemin Industries Inc.
• 14. Merck & Co., Inc.
• 15. Novartis AG
• 16. Phibro Animal Health Corporation
• 17. Qilu Animal Health Products Co., Ltd.
• 18. Salius Pharma Pvt. Ltd.
• 19. TOKU-E
• 20. VH Group
• 21. Virbac Group
• 22. VIVAN Life Sciences Pvt. Limited
• 23. Zoetis Inc.